Patent Assignment
Reel/Frame 061595/0066
Security Agreement (First Lien)
Recorded: 2022-10-04
Pages: 23
Assignors
BAUSCH HEALTH US, LLC
Executed: 2022-09-30
BAUSCH HEALTH AMERICAS, INC.
Executed: 2022-09-30
MEDICIS PHARMACEUTICAL CORPORATION
Executed: 2022-09-30
ORAPHARMA, INC.
Executed: 2022-09-30
PRECISION DERMATOLOGY, INC.
Executed: 2022-09-30
SALIX PHARMACEUTICALS, INC.
Executed: 2022-09-30
SALIX PHARMACEUTICALS, LTD.
Executed: 2022-09-30
SANTARUS, INC.
Executed: 2022-09-30
SOLTA MEDICAL, INC.
Executed: 2022-09-30
Assignee
THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
240 GREENWICH STREET, NEW YORK, NEW YORK, 10286
Covered Properties
(361)
Guanylate Cyclase Receptor Agonists for the Treatment of Tissue Inflammation and Carcinogenesis
Temperature Controlled Heating Device and Method to Heat a Selected Area of a Biological Body
Controlled Release Dosage Forms
Compositions and Methods for Enhancing Corticosteroid Delivery
Compositions and Methods for Enhancing Corticosteroid Delivery
Ultrasonic Device and Method for Tissue Coagulation
Synthesis and Use of 2'-Substituted-N6-Modified Nucleosides
Adaptive Control of Optical Pulses for Laser Medicine
Two-Dimensional Optical Scan System Using a Counter-Rotating Disk Scanner
Colonic Purgative Composition with Soluble Binding Agent
Method and Apparatus for Monitoring and Controlling Laser-Induced Tissue Treatment
Disposable Transducer Seal
Ultrasound Therapy Head with Movement Control
Methods for Effecting Regression of Tumor Mass and Size in a Metastasized Pancreatic Tumor
Apparatus and Method to Apply Substances to Tissue
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
Optical Pattern Generator Using a Single Rotating Component
Method for the Treatment of Acne
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
High Speed, High Efficiency Optical Pattern Generator Using Rotating Optical Elements
Methods and apparatus for coupling a HIFU transducer to a skin surface
Apparatus and Methods for the Destruction of Adipose Tissue
Treatment Apparatus and Methods for Delivering Energy at Multiple Selectable Depths in Tissue
Stabilized Steroid Composition and Method for Its Preparation
Modified Release Tablet of Bupropion Hydrochloride
Modified Release Formulations of a Bupropion Salt
Alpha Hydroxy Acid Sustained Release Formulation
Electrode Assembly and Handpiece with Adjustable System Impedance, and Methods of Operating an Energy-Based Medical System to Treat Tissue
Laser-induced transepidermal elimination of content by fractional photothermolysis
Articulated Arm for Delivering a Laser Beam
Optical System Having Aberrations for Transforming a Gaussian Laser-Beam Intensity Profile to a Quasi-Flat-Topped Intensity Profile in a Focal Region of the Optical System
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives
Teeth Whitening Composition and Methods
Compositions and Methods for Enhancing Corticosteroid Delivery
Minocycline Oral Dosage Forms for the Treatment of Acne
Minocycline Oral Dosage Forms for the Treatment of Acne
Minocycline Oral Dosage Forms for the Treatment of Acne
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Apparatus and Method for Adjustable Fractional Optical Dermatological Treatment
Apparatus and Method for Adjustable Fractional Optical Dermatological Treatment
Substituted Arylamino -1,2,3,4-Tetrahydro Naphthalenes and -2,3-Dihydro-1H-Indenes as Potassium Channel Modulators
Bupropion Hydrobromide and Therapeutic Applications
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives
N-[2-Amino-4-(Phenylmethoxy)Phenyl] Amides and Related Compounds as Potassium Channel Modulators
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives
Amorphous Form of Rifaximin and Processes for Its Preparation
Bupropion Hydrobromide and Therapeutic Applications
Disposable Transducer Seal
Pivoting Roller Tip for Dermatological Treatment Apparatus
Method and apparatus for monitoring and controlling laser-induced tissue treatment
Modified-Release Formulations of a Bupropion Salt
Methods and Compositions for Increasing Solubility of Azole Drug Compounds That Are Poorly Soluble in Water
Slip Ring Spacer and Method for Its Use
Method for Stabilizing Polypeptides Lacking Methionine
Colonic Purgative Composition with Soluble Binding Agent
Treatment of Alopecia by Micropore Delivery of Stem Cells
Optical Pattern Generator Using a Single Rotating Component
Optical Pattern Generator Using a Single Rotating Optical Component with Ray-Symmetry-Induced Image Stability
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Method for Reducing Pain of Dermatological Treatments
Derivatives of 4-(N-Azacycloalkyl) Anilides as Potassium Channel Modulators
Treatment Apparatus and Methods for Delivering High Frequency Energy Across Large Tissue Areas
Naphthyridine Derivatives as Potassium Channel Modulators
Rifaximin Anti-Rectal Dysfunction Preparation
Adaptive Control of Optical Pulses for Laser Medicine
Silicone Gel-Based Compositions for Wound Healing and Scar Reduction
Minocycline Oral Dosage Forms for the Treatment of Acne
Reconnectable Handpieces for Optical Energy Based Devices and Methods for Adjusting Device Components
Device for Delivering Medicinal Implants
Medicinal Implant Cartridge
Actuators for Device for Delivering Medicinal Implants
Controlled Release Dosage Forms
Optical Pattern Generators Using Axicon Segments
Therapy Head for Use with an Ultrasound System
Forms of Rifaximin and Uses Thereof
Methods for Treating Diarrhea-Associated Irritable Bowel Syndrome
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Photopolymerization Material for Gums Isolation
Method for the Treatment of Acne and Certain Dosage Forms Thereof
Bupropion Hydrobromide Polymorphs
Apparatus and Methods for the Destruction of Adipose Tissue
Optical Pattern Generator Using a Single Rotating Component
Bupropion Hydrobromide and Therapeutic Applications
Medicinal Implant Device and Cartridge
Agonists of Guanylate Cyclase Useful for the Treatment of Hypercholesterolemia, Atherosclerosis, Coronary Heart Disease, Gallstone, Obesity and Other Cardiovascular Diseases
Tissue Treatment Apparatus with Functional Mechanical Stimulation and Methods for Reducing Pain During Tissue Treatments
Tissue Treatment Apparatus and Systems with Pain Mitigation and Methods for Mitigating Pain During Tissue Treatments
Colonic Purgative Composition with Soluble Binding Agent
Forms of Rifaximin and Uses Thereof
Ultrasonic Treatment of Adipose Tissue at Multiple Depths
Analysis of Real Time Backscatter Data for Fault Signal Generation in a Medical Hifu Device
Transducer Cartridge for an Ultrasound Therapy Head
Cartridge for Use with an Ultrasound Therapy Head
Liquid Degas System
Medical Ultrasound Device with Liquid Dispensing Device Coupled to a Therapy Head
Compositions and Methods for Treating Diseases of the Nail
Patent:
8,039,494 →
Application:
12/803,848 →
Tissue Treatment Systems with High Powered Functional Electrical Stimulation and Methods for Reducing Pain During Tissue Treatments
Stabilized Steroid Composition and Method for its Preparation
Granular Sustained Release Preparation and Production Thereof
Extended-Release Minocycline Dosage Forms
Patent:
8,722,650 →
Application:
12/861,424 →
Pump Systems and Methods for Storing and Dispensing a Plurality of Precisely Measured Unit-Doses of Imiquimod Cream
Minocycline Oral Dosage Forms for the Treatment of Acne
Synthesis and Use of 2'-Substituted-N6-Modified Nucleosides
Stereoselective Synthesis of Metyrosine
Suspension Containing Micronized Benzoyl Peroxide
Methods and Compositions for Increasing Solubility of Azole Drug Compounds That Are Poorly Soluble in Water
Selective Lysing of Cells Using Ultrasound
Apparatus and Method for Adjustable Fractional Optical Dermatological Treatment
Apparatus and Method for Adjustable Fractional Optical Dermatological Treatment
Methods of Treating Travelers Diarrhea and Hepatic Encephalopathy
Handpiece for Ultrasonic Medical Devices Including Seal for Mechanical Isolation of Ultrasonic Driver Assembly
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Handheld Apparatus for Use by a Non-Physician Consumer to Fractionally Resurface the Skin of the Consumer
Optical Pattern Generator Using a Single Rotating Component
High Oil-Content Emollient Aerosol Foam Compositions
Methods of Treating Traveler's Diarrhea and Hepatic Encephalopathy
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives for the Treatment of Males
Substituted Arylamino-1,2,3,4-Tetrahydro Naphthalenes and -2,3-Dihydro-1H-Indenes as Potassium Channel Modulators
Forms of Rifaximin and Uses Thereof
Device for Delivering Medicinal Implants
Combination Therapy with Cryosurgery and Low Dosage Strength Imiquimod to Treat Actinic Keratosis
Application:
13/168,796 →
Publication:
US 2011/0319811
2 X 2 X 2 Week Treatment Regimen for Treating Actinic Keratosis with Pharmaceutical Compositions Formulated with 2.5% Imiquimod
2 X 2 X 2 Week Dosing Regimen for Treating Actinic Keratosis with Pharmaceutical Compositions Formulated with 3.75 % Imiquimod
Method of Treating Actinic Keratosis with 3.75% Imiquimod Cream
Compositions and Methods for Treating Diseases of the Nail
Cooled Medical Handpiece
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Modified Atmosphere Packaging for Ultrasound Transducer Cartridge
Power Assisted Lipoplasty
Pharmaceutical Formulations Containing Corticosteroids for Topical Administration
Forms of Rifaximin and Uses Thereof
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Method and Apparatus for Breath Testing
Forms of Rifaximin and Uses Thereof
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Method of Inhibiting Bile Acid Absorption by Administering An Agonist of a Guanylate Cyclase Receptor
Forms of Rifaximin and Uses Thereof
Methods of Treating Dermatological Disorders and Inducing Interferon Biosynthesis with Shorter Durations of Imiquimod Therapy
Lower Dosage Strength Imiquimod Formulations and Short Dosing Regimens for Treating Genital and Perianal Warts
2 X 2 X 2 Week Dosing Regimen for Treating Actinic Keratosis with Pharmaceutical Compositions Formulated with 3.75 % Imiquimod
Forms of Rifaximin and Uses Thereof
Forms of Rifaximin and Uses Thereof
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Combination Therapy with Low Dosage Strength Imiquimod and Photodynamic Therapy to Treat Actinic Keratosis
Forms of Rifaximin and Uses Thereof
Bupropion Hydrobromide Polymorphs
Ultrasonic Probe for Treating Cellulite
Methods of Treating Traveler's Diarrhea and Hepatic Encephalopathy
Apparatus and Methods for the Destruction of Adipose Tissue
Ultrasonic Transducer
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Patterned Electrodes for Tissue Treatment Systems
Methods of Treating Hepatic Encephalopathy
Methods for Treating Irritable Bowel Syndrome (Ibs)
Antibody Formulations
Methods of Treating Hepatic Encephalopathy
Transducer Cartridge for an Ultrasound Therapy Head
Compositions for Increasing Solubility of Azole Drug Compounds That Are Poorly Soluble in Water
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Controlled Release Pharmaceutical Dosage Forms
Methods of Treating Dermatological Disorders and Inducing Interferon Biosynthesis with Shorter Durations of Imiquimod Therapy
Methods of Treating Hepatic Encephalopathy
Forms of Rifaximin and Uses Thereof
Tissue Treatment Apparatus with Functional Mechanical Stimulation and Methods for Reducing Pain During Tissue Treatments
Compositions and Methods for Treating Diseases of the Nail
New Forms of Rifaximin and Uses Thereof
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Medicinal Implant Device and Cartridge
Process of Preparing Guanylate Cyclase C Agonists
Silicone Gel-Based Compositions for Wound Healing and Scar Reduction
Forms of Rifaximin and Uses Thereof
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Methods of Treating Dermatological Disorders and Inducing Interferon Biosynthesis with Shorter Durations of Imiquimod Therapy
Lower Dosage Strength Imiquimod Formulations and Short Dosing Regimens for Treating Genital and Perianal Warts
Topical Pharmaceutical Foam Composition
Agonists of Guanylate Cyclase and Their Uses
Compositions Useful For The Treatment Of Gastrointestinal Disorders
Agonists Of Guanylate Cyclase And Their Uses
Kinetin/Zeatin Topical Formulation
Agonists of Guanylate Cyclase Useful For the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Formulations of Rifaximin and Uses Thereof
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Method for Preparing a Rifaximin Product
Forms of Rifaximin and Uses Thereof
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Rifaximin Derivative and Uses Thereof
High Oil-Content Emollient Aerosol Foam Compositions
Tissue Treatment Apparatus and Systems with Pain Mitigation and Methods for Mitigating Pain During Tissue Treatments
Pharmaceutical Formulations Containing Corticosteroids for Topical Administration
Anti-VLA1 (CD49A) Antibody Pharmaceutical Compositions
Controlled-Release Solid Dosage Forms of Mesalamine
Stereoselective Synthesis of Metyrosine
Modified Release Formulations Of A Bupropion Salt
Compositions and Methods for Treating Diseases of the Nail
Power Assisted Lipoplasty
Stabilized Efinaconazole Compositions
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Anti-Infective Methods, Compositions, and Devices
Forms of Rifaximin and Uses Thereof
Use of Aminosalicylates in Diarrhoea-Predominent Irritable Bowel Syndrome
Methods of Treating Traveler's Diarrhea and Hepatic Encephalopathy
Methods of Treating Hepatic Encephalopathy
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Pump Systems and Methods for Storing and Dispensing a Plurality of Precisely Measured Unit-Doses of Imiquimod Cream
Rifaximin Derivative and Uses Thereof
Agonists of Guanylate Cyclase Useful for the Treatment of Hypercholesterolemia, Atherosclerosis, Coronary Heart Disease, Gallstone, Obesity and Other Cardiovascular Diseases
Compositions and Methods for Treating Diseases of the Nail
Lower Dosage Strength Imiquimod Formulations and Short Dosing Regimens for Treating Genital and Perianal Warts
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Ultra-Pure Agonists of Guanylate Cyclase C, Method of Making and Using Same
Formulations of Calcium and Phosphate for Oral Inflammation
Forms of Rifaximin and Uses Thereof
Compositions and Methods for Teeth Whitening
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Forms of Rifaximin and Uses Thereof
Rifaximin Derivative and Uses Thereof
Topical Compositions and Methods for Treating Psoriasis
2 x 2 x 2 WEEK DOSING REGIMEN FOR TREATING ACTING KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 3.75% IMIQUIMOD
Methods of Treating Hepatic Encephalopathy
Compositions Useful for the Treatment of Gastrointestinal Disorders
Compositions and Methods for Treating Diseases of the Nail
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Ibs Microbiota and Uses Thereof
Agonists of Guanylate Cyclase and Their Uses
Methods for Treating Irritable Bowel Syndrome (Ibs)
Process of Preparing Guanylate Cyclase C Agonisys
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Methods of Treating Hepatic Encephalopathy
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Kinetin/Zeatin Topical Formulation
Stabilized Efinaconazole Compositions
Pharmaceutical Formulations Containing Corticosteroids for Topical Administration
Agonists of Guanylate Cyclase and Their Uses
Methods of Treating Hepatic Encephalopathy
Compositions and Methods for Treating Diseases of the Nail
Compositions and Methods for Treating Diseases of the Nail
Methods for Treating Irritable Bowel Syndrome (Ibs)
Topical Compositions and Methods for Treating Psoriasis
Use of Aminosalicylates in Diarrhoea-Predominent Irritable Bowel Syndrome
Methods of Treating Hepatic Encephalopathy
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Kinetin/Zeatin Topical Formulation
Pharmaceutical Formulations Containing Corticosteroids for Topical Administration
Lower Dosage Strength Imiquimod Formulations and Short Dosing Regimens for Treating Genital and Perianal Warts
Ultra-Pure Agonists of Guanylate Cyclase C, Method of Making and Using Same
Formulations and Methods for Treating Ulcerative Colitis
Topical Pharmaceutical Compositions for Treating Skin Conditions
Controlled-Release Solid Dosage Forms of Mesalamine
Compositions and Methods for Treating Diseases of the Nail
Agonists of Guanylate Cyclase and Their Uses
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Pharmaceutical Formulations Containing Corticosteroids for Topical Administration
Topical Compositions and Methods for Treating Skin Diseases
Topical Compositions and Methods for Treating Skin Diseases
Application:
16/179,576 →
Publication:
US 2019/0133943
2 x 2 x 2 WEEK DOSING REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 3.75% IMIQUIMOD
Tissue Treatment Apparatus and Systems with Pain Mitigation and Methods for Mitigating Pain During Tissue Treatments
Multidose Package, Course and Method of Treatment for Delivering Predetermined Multiple Doses of a Pharmaceutical
Anti-Infective Methods, Compositions, and Devices
Lower Dosage Strength Imiquimod Formulations and Short Dosing Regimens for Treating Genital and Perianal Warts
Solid Dispersion Forms of Rifaximin
Topical Pharmaceutical Compositions for Treating Skin Conditions
Polymeric Emulsion Delivery Systems
Methods of Treating Hepatic Encephalopathy
Stabilized Efinaconazole Formulations
Agonists of Guanylate Cyclase and Their Uses
Encrypted Memory Device
Methods and Apparatus for Pumping Coolant to an Energy Delivery Device
Pain Mitigation by Mechanical Stimulation When Treating Tissue with Electromagnetic Energy
Redundant Traces for Flexible Circuits Used in an Energy Delivery Device
Methods for manufacturing phenoxyethanol
Compositions and Methods for Treating Diseases of the Nail
Methods for Treating Irritable Bowel Syndrome (Ibs)
Topical Compositions and Methods for Treating Acne Vulgaris
Application:
16/822,831 →
Publication:
US 2020/0297684
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Application:
16/882,059 →
Publication:
US 2020/0283480
Formulations of Rifaximin and Uses Thereof
Application:
16/916,421 →
Publication:
US 2020/0397904
Transducer Cartridge for an Ultrasound Therapy Head
Application:
16/919,671 →
Ultra-Pure Agonists of Guanylate Cyclase C, Method of Making and Using Same
Topical Compositions
Anti-Infective Methods, Compositions, and Devices
Use of Methylnaltrexone to Attenuate Tumor Progression
Application:
17/063,470 →
Publication:
US 2021/0121456
Compositions and Methods for Treating Diseases of the Nail
Application:
17/092,473 →
Publication:
US 2021/0121572
Stabilized Efinaconazole Compositions as Antifungals
Topical Compositions and Methods for Treating Psoriasis
Tissue Treatment Apparatus and Systems with Pain Mitigation and Methods for Mitigating Pain During Tissue Treatments
Solid Dispersion Forms of Rifaximin
Lower Dosage Strength Imiquimod Formulations and Short Dosing Regimens for Treating Genital and Perianal Warts
Agonists of Guanylate Cyclase and Their Uses
Application:
17/184,256 →
Publication:
US 2021/0379142
Methods for Treating Irritable Bowel Syndrome (Ibs)
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Application:
17/207,222 →
Publication:
US 2021/0205406
Methods of Treating Hepatic Encephalopathy
Ceramic Applicator for Transcutaneous Delivery of Energy
Microblade Structure and Method of Treating Tissue
Topical Compositions and Methods for Treating Psoriasis
Ultra-Pure Agonists of Guanylate Cyclase C, Method of Making and Using Same
Application:
17/397,796 →
Publication:
US 2022/0119449
Solid Dispersion Forms of Rifaximin
Solid Dispersion Forms of Rifaximin
Ultra-Pure Agonists of Guanylate Cyclase C, Method of Making and Using Same
Pharmaceutical Formulations Useful for Inhibiting Acid Secretion and Methods for Making and Using Them
Application:
17/489,939 →
Publication:
US 2022/0133778
Liquid Oral Dosage Formulations of Methylnaltrexone
Application:
17/495,413 →
Publication:
US 2022/0096461
Use of Methylnaltrexone and Rifaximin for Treatment of Increased Gut Permeability or Associated Disorders
Application:
17/529,818 →
Publication:
US 2022/0175764
Compositions and Methods for Treating Diseases of the Nail
Redundant Traces for Flexible Circuits Used in an Energy Delivery Device
Methods of Treating Nonalcoholic Fatty Liver Disease (Nafld) Using Il-17RA Antibody
Application:
17/642,130 →
Publication:
US 2022/0380449
Methods of Treating Hepatic Encephalopathy
Methods of Using Rifamycin Sv for the Treatment of Sickle Cell Disease
Application:
17/687,534 →
Publication:
US 2022/0280478
Topical Pharmaceutical Compositions for Treating Skin Conditions
Application:
17/714,090 →
Publication:
US 2022/0226271
Topical Compositions and Methods for Treating Skin Diseases
Polymeric Emulsion Delivery Systems
Application:
17/747,938 →
Publication:
US 2023/0000768
Rifaximin Liquid Formulations
Application:
17/763,615 →
Publication:
US 2022/0378758
Topical Compositions Comprising a Macrolide Immunosuppressant
Application:
17/814,474 →
Publication:
US 2022/0362232
Methods and Apparatus for Pumping Coolant to an Energy Delivery Device
Topical Compositions
Rifaximin Complexes
Methods for Treating Irritable Bowel Syndrome (Ibs)
Electrode Assemblies with Non-Contact Temperature Sensing for Thermal Measurements
Ultrasonic Probes for Producing Multiple Cavitation Volumes
Application:
17/909,028 →
Publication:
US 2023/0087566
Removable Tip of a Handpiece for a Dermatological Optical Delivery System
Patent:
595,407 →
Application:
29/296,766 →
Removable Tip of a Handpiece for a Dermatological Optical Delivery System
Patent:
608,888 →
Application:
29/305,884 →
Removable Tip of a Handpiece for a Dermatological Optical Delivery System
Patent:
604,843 →
Application:
29/305,886 →
Handpiece for a Dermatological Optical Delivery System
Patent:
601,697 →
Application:
29/305,887 →
Dermatological Optical Delivery System
Patent:
612,941 →
Application:
29/305,888 →
Handpiece for a Dermatological Optical Delivery System
Patent:
640,373 →
Application:
29/305,889 →
Light-Emitting Therapeutic Device
Patent:
589,154 →
Application:
29/318,385 →
Light-Emitting Therapeutic Device
Patent:
596,748 →
Application:
29/329,143 →
Ultrasonic Amplifier
Patent:
669,992 →
Application:
29/362,163 →
Hand Piece for Ultrasound Therapy Head
Patent:
629,525 →
Application:
29/363,081 →
Therapy Cap for Ultrasonic Therapy Head
Patent:
629,526 →
Application:
29/363,084 →
Ultrasound Therapy Cap Connection
Patent:
629,527 →
Application:
29/363,086 →
Ultrasound Therapy Base Unit
Patent:
629,523 →
Application:
29/363,089 →
Console for Use in Power Assisted Lipoplasty
Patent:
669,993 →
Application:
29/375,932 →
Handpiece for Use in Power Assisted Lipoplasty
Patent:
674,479 →
Application:
29/375,936 →
Handpiece
Patent:
680,640 →
Application:
29/402,984 →
Light Therapy Device
Patent:
921,212 →
Application:
29/720,106 →
Light Therapy Device
Patent:
922,595 →
Application:
29/720,107 →
Light Therapy Device
Patent:
928,975 →
Application:
29/720,109 →
Access Device
Patent:
940,133 →
Application:
29/720,111 →
Vented Tip
Patent:
970,741 →
Application:
29/763,116 →
Light Therapy Device
Patent:
959,003 →
Application:
29/780,736 →
Light Therapy Device
Patent:
959,004 →
Application:
29/788,730 →
Access Device
Patent:
959,428 →
Application:
29/789,564 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Release of Security Interest
Mar 6, 2019
From: CRG SERVICING LLC
To: SYNERGY PHARMACEUTICALS INC.
Reel/Frame 048521/0005 →
Security Interest
Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
Merger
Apr 19, 2019
From: VALEANT INTERNATIONAL BERMUDA
To: VALEANT HOLDINGS IRELAND
Reel/Frame 048939/0764 →
Assignment of Assignor's Interest
Apr 22, 2019
From: VALEANT HOLDINGS IRELAND
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 048954/0900 →
Change of Name
Jun 5, 2019
From: MEDICIS TECHNOLOGIES CORPORATION
To: LIPOSONIX, INC.
Reel/Frame 049377/0234 →
Intellectual Property Security Agreement
Jul 3, 2019
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 049672/0652 →
Assignment of Assignor's Interest
Apr 9, 2020
From: SYNERGY PHARMACEUTICALS INC.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 052358/0134 →
Merger
May 12, 2021
From: SOUND SURGICAL TECHNOLOGIES LLC
To: SOLTA MEDICAL, INC.
Reel/Frame 056214/0690 →
Merger
May 12, 2021
From: RELIANT TECHNOLOGIES, INC.
To: RELIANT TECHNOLOGIES, LLC
Reel/Frame 056218/0067 →
Change of Name
May 12, 2021
From: MEDICIS TECHNOLOGIES CORPORATION
To: LIPOSONIX, INC.
Reel/Frame 056228/0375 →
Merger
May 13, 2021
From: AESTHERA; LIPOSONIX, INC.
To: SOLTA MEDICAL, INC.
Reel/Frame 056227/0174 →
Merger
May 14, 2021
From: RELIANT TECHNOLOGIES, LLC
To: SOLTA MEDICAL, INC.
Reel/Frame 056244/0936 →
Merger
May 17, 2021
From: LIPOSONIX, INC.
To: SOLTA MEDICAL, INC.
Reel/Frame 056257/0362 →
Security Interest
Jun 8, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 056811/0814 →
Security Interest
Oct 5, 2021
From: BAUSCH & LOMB IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 057821/0800 →
Security Agreement
Feb 10, 2022
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
To: THE BANK OF NEW YORK MELLON
Reel/Frame 059121/0001 →
Merger
May 10, 2022
From: LIPOSONIX, INC.
To: SOLTA MEDICAL, INC.
Reel/Frame 059878/0170 →
Security Interest
Jun 13, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 060346/0705 →
Security Agreement (Second Lien)
Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
Security Agreement (First Lien)
Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061882/0708 →
Security Agreement (Second Lien)
Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 062078/0276 →
Intellectual Property Security Agreement
Jun 9, 2023
From: BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 063942/0001 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →